Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area others cam kinase ii'

Search results for: 'research area others cam kinase ii'

Items 31-40 of 85

Page
per page
  1. PRT062607 Hydrochloride
    A3736 PRT062607 Hydrochloride
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and selective
      ≥21.5 mg/mL
  2. (R)-Crizotinib
    A3020 (R)-Crizotinib
     2 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
  3. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  4. SGX-523
    A1196 SGX-523
     1 Citation
    Target: MET
    Summary: MET inibitor, highly selective, ATP-competitive
      ≥17.95 mg/mL
  5. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR inhibitor
      ≥21.35 mg/mL
  6. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: Selective IGF-1R/IR inhibitor
      ≥42.6 mg/mL
  7. Quizartinib (AC220)
    A5793 Quizartinib (AC220)
    Target: FLT3
    Summary: FLT3 inhibitor,potent and selective
      ≥28.03 mg/mL
  8. Crenolanib (CP-868596)
    A8307 Crenolanib (CP-868596)
     1 Citation
    Target: FLT3|PDGFR
    Summary: PDGFR-β inhibitor,potent and selective
      ≥22.2 mg/mL
  9. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,non-ATP-competitive
      ≥18.47 mg/mL
  10. R428
    A8329 R428
     10 Citation
    Summary: Selective Axl inhibitor
      ≥25 mg/mL

Items 31-40 of 85

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 5item
  2. Axl 4item
  3. ALK 6item
  4. Broad Spectrum Protein Kinase Inhibitor 1 item
  5. c-FMS 1 item
  6. c-Kit 2item
  7. c-MET 8item
  8. c-RET 1 item
  9. CSF-1R 2item
  10. EGFR 10item
  11. EphB4 1 item
  12. FAK 3item
  13. FGFR 6item
  14. FLT3 5item
  15. HER2 5item
  16. IGF1R 3item
  17. IRAK 2item
  18. ITK 1 item
  19. LRRK2 3item
  20. PDGFR 8item
  21. Pyk2 2item
  22. Spleen Tyrosine Kinase (Syk) 5item
  23. Src 5item
  24. Tie-2 2item
  25. Trk 2item
  26. VEGFR 15item
Reversibility
  1. Reversible 7item
  2. Irreversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 3item
  3. Aurora Kinases 1 item
  4. CSF-1R 2item
  5. FLT3 5item
  6. Eph Receptors 2item
  7. VEGFR 18item
  8. PDGFR 11item
  9. c-Kit 6item
  10. RET 3item
  11. IRAK 2item
  12. Bcr-Abl 8item
  13. FGFR 6item
  14. MET 5item
  15. Src 6item
  16. Trk Receptors 2item
  17. EGFR 10item
  18. FAK 3item
  19. BMP and Other Activin Receptors 1 item
  20. JAK 2item
  21. Syk 5item
  22. ErbB 2item
  23. c-MET 5item
  24. PKC 1 item
  25. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  26. Lyn 1 item
  27. HER2 2item
  28. Pyk2 3item
  29. LRRK2 3item
  30. Insulin and Insulin-like Receptors 2item
  31. ALK 3item
  32. ROS1 1 item
  33. PKG 1 item
  34. PKA 1 item
  35. Myosin light chain kinases (MLCKs) 1 item
  36. Insulin-like growth factors (IGFs) 1 item
  37. Tie-2 1 item
  38. c-Fyn 1 item
  39. Insulin Receptors 1 item
  40. IRG-1R 1 item
  41. ZAP-70 1 item
  42. TAM kinase 1 item
  43. AXL 1 item
  44. c-Fms tyrosine kinase 1 item
  45. Lyn kinase 1 item
  46. ITK 1 item
  47. DCLK2 1 item
  48. tropomyosin receptor kinase 1 item
  49. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 78item
  2. Cell Experiments 47item
Related Disease
  1. Acute Myeloid Leukemia 5item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Bladder Cancer 3item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 17item
  7. Cancer 61item
  8. Cervical Cancer 1 item
  9. Cholangiocarcinoma 1 item
  10. Clear Cell Renal Cell Carcinoma 1 item
  11. Colon Cancer 2item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 10item
  14. Glioblastoma 5item
  15. Glioma 3item
  16. Hepatocellular Carcinoma 3item
  17. Leukemia 2item
  18. Liver Cancer 2item
  19. Lung Cancer 6item
  20. Lung Carcinoma 3item
  21. Lymphoma 5item
  22. Melanoma 3item
  23. Multiple Myeloma 3item
  24. Neuroblastoma 1 item
  25. Non-small Cell Lung Cancer 3item
  26. Ovarian Cancer 6item
  27. Pancreatic Cancer 9item
  28. Prostate Cancer 7item
  29. Pulmonary Arterial Hypertension 1 item
  30. Renal Cancer 2item
  31. Renal Cell Carcinoma 4item
  32. Rheumatoid Arthritis 2item
  33. Thyroid Cancer 3item